Rubicon Research logo and IPO banner at a stock exchange podium.

Rubicon Research Secures ₹619 Crore from Anchor Investors Before IPO Launch

Rubicon Research, a Mumbai-based pharmaceutical company, has secured ₹619 crore from anchor investors ahead of its public issue. The strong anchor round signals institutional trust in the company’s model, its export focus, and its R&D pipeline.  According to reports from authentic sources, the public offer opens this week, and proceeds will target debt repayment, R&D…

Rubicon Research

Rubicon Research IPO Guide: Date, Price, Review & Allotment Updates

The Rubicon Research IPO is one of the most anticipated public offerings in India’s pharmaceutical sector this year. Scheduled to open on October 9, 2025, and close on October 13, 2025, this IPO has garnered significant attention from investors. With a price band set between ₹461 and ₹485 per share, Rubicon Research aims to raise…